For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Emergent Biosolutions Inc (NYSE: EBS) closed at $7.56 in the last session, down -0.26% from day before closing price of $7.58. In other words, the price has decreased by -$0.26 from its previous closing price. On the day, 0.86 million shares were traded. EBS stock price reached its highest trading level at $7.62 during the session, while it also had its lowest trading level at $7.4502.
Ratios:
We take a closer look at EBS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.60. For the most recent quarter (mrq), Quick Ratio is recorded 3.00 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16. The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’25 when Zoon Kathryn C sold 7,086 shares for $8.87 per share. The transaction valued at 62,853 led to the insider holds 71,799 shares of the business.
KATHRYN ZOON bought 7,086 shares of EBS for $62,853 on Aug 15 ’25. On Aug 12 ’25, another insider, DeGolyer Donald W, who serves as the Director of the company, sold 7,844 shares for $8.65 each. As a result, the insider received 67,831 and left with 137,659 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 403334304 and an Enterprise Value of 812134336. As of this moment, Emergent’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.08, and their Forward P/E ratio for the next fiscal year is 7.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.47 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 0.954 whereas that against EBITDA is 3.746.
Stock Price History:
The Beta on a monthly basis for EBS is 2.05, which has changed by -0.02702701 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $12.73, while it has fallen to a 52-week low of $4.02. The 50-Day Moving Average of the stock is -0.03%, while the 200-Day Moving Average is calculated to be 1.80%.
Shares Statistics:
According to the various share statistics, EBS traded on average about 1.29M shares per day over the past 3-months and 999020 shares per day over the past 10 days. A total of 53.70M shares are outstanding, with a floating share count of 51.05M. Insiders hold about 4.31% of the company’s shares, while institutions hold 74.47% stake in the company. Shares short for EBS as of 1755216000 were 9815705 with a Short Ratio of 7.63, compared to 1752537600 on 9056841. Therefore, it implies a Short% of Shares Outstanding of 9815705 and a Short% of Float of 18.59.